Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 18/20 | 0.55 |
| ▸ | CA1 | P00915 | 17/20 | 0.55 |
| ▸ | MMP1 | P03956 | 6/20 | 0.55 |
| ▸ | MMP2 | P08253 | 6/20 | 0.55 |
| ▸ | MMP9 | P14780 | 6/20 | 0.55 |
| ▸ | MMP8 | P22894 | 6/20 | 0.55 |
| ▸ | MMP13 | P45452 | 6/20 | 0.55 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | F2 | P00734 | 1/20 | 0.37 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.37 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.37 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1618140 | 0.90 | CA1 (0.47) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL1618321 | 0.88 | CA1 (0.43) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL16594047 | 0.86 | CA2 (0.57) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL1618706 | 0.86 | CA2 (0.47) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL27241359 | 0.84 | CA2 (0.55) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL27241367 | 0.84 | CA1 (0.41) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL1618550 | 0.79 | CA1 (0.41) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL1618620 | 0.79 | CA2 (0.48) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL8392999 | 0.79 | CA2 (0.59) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL7174847 | 0.79 | THRB (0.43) | CA2CA1MMP1MMP2MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7678941-B2 | Polyoxyalkylene ammonium salts and their use as antistatic agents | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2010-03-16 | — | — | US | disclosed |
| US-20080039654-A1 | POLYOXYALKYLENE AMMONIUM SALTS AND THEIR USE AS ANTISTATIC AGENTS | 3M INNOVATIVE PROPERTIES COMPANY | 2008-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080039654-A1 | POLYOXYALKYLENE AMMONIUM SALTS AND THEIR USE AS ANTISTATIC AGENTS | ALKBH5, ALKBH2, ALKBH3 | CA2 22/4885CA1 221/4885MMP1 652/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.